CA2319703C - Facteur-8 de differenciation de la croissance - Google Patents

Facteur-8 de differenciation de la croissance Download PDF

Info

Publication number
CA2319703C
CA2319703C CA002319703A CA2319703A CA2319703C CA 2319703 C CA2319703 C CA 2319703C CA 002319703 A CA002319703 A CA 002319703A CA 2319703 A CA2319703 A CA 2319703A CA 2319703 C CA2319703 C CA 2319703C
Authority
CA
Canada
Prior art keywords
gdf
leu
pro
lys
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002319703A
Other languages
English (en)
Other versions
CA2319703A1 (fr
Inventor
Se-Jin Lee
Alexandra C. Mcpherron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
School of Medicine of Johns Hopkins University
Original Assignee
School of Medicine of Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by School of Medicine of Johns Hopkins University filed Critical School of Medicine of Johns Hopkins University
Publication of CA2319703A1 publication Critical patent/CA2319703A1/fr
Application granted granted Critical
Publication of CA2319703C publication Critical patent/CA2319703C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knockout animals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Abstract

Cette invention concerne un animal transgénique non humain faisant partie d'une espèce aviaire, bovine, ovine et porcine et présentant un transgène dont l'activité entrave la production et/ou l'activité du facteur-8 de différentiation de la croissance (GDF-8) intégré aux chromosomes des cellules germinales dudit animal. L'invention concerne également des techniques d'obtention et des méthodes de traitement de tels animaux, humains y compris, au moyen d'anticorps dirigés contre le facteur-8 ou de séquences antisens dudit facteur. Les animaux traités de cette manière se caractérisent par une masse tissulaire et osseuse accrue.
CA002319703A 1998-02-05 1999-02-05 Facteur-8 de differenciation de la croissance Expired - Lifetime CA2319703C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1907098A 1998-02-05 1998-02-05
US09/019,070 1998-02-05
US12418098A 1998-07-28 1998-07-28
US09/124,180 1998-07-28
PCT/US1999/002511 WO1999040181A1 (fr) 1998-02-05 1999-02-05 Facteur-8 de differenciation de la croissance

Publications (2)

Publication Number Publication Date
CA2319703A1 CA2319703A1 (fr) 1999-08-12
CA2319703C true CA2319703C (fr) 2005-09-20

Family

ID=26691808

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002319703A Expired - Lifetime CA2319703C (fr) 1998-02-05 1999-02-05 Facteur-8 de differenciation de la croissance

Country Status (3)

Country Link
AU (1) AU2586199A (fr)
CA (1) CA2319703C (fr)
WO (1) WO1999040181A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7566768B1 (en) 1995-10-26 2009-07-28 The Johns Hopkins University School Of Medicine Promyostatin peptides and methods of using same
US7393682B1 (en) 1993-03-19 2008-07-01 The Johns Hopkins University School Of Medicine Polynucleotides encoding promyostatin polypeptides
US6465239B1 (en) * 1993-03-19 2002-10-15 The John Hopkins University School Of Medicine Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species
EP1333035A3 (fr) 1993-03-19 2004-07-07 The Johns Hopkins University School Of Medicine Facteur GDF-8 de différentiation de croissance
US5994618A (en) 1997-02-05 1999-11-30 Johns Hopkins University School Of Medicine Growth differentiation factor-8 transgenic mice
US7332575B2 (en) 1994-03-18 2008-02-19 The Johns Hopkins University School Of Medicine Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
US20030167492A1 (en) 1994-07-08 2003-09-04 Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
US6891082B2 (en) 1997-08-01 2005-05-10 The Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a truncated activintype II receptor
US6656475B1 (en) * 1997-08-01 2003-12-02 The Johns Hopkins University School Of Medicine Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
US6369201B1 (en) 1998-02-19 2002-04-09 Metamorphix International, Inc. Myostatin multimers
WO2001053350A1 (fr) 2000-01-18 2001-07-26 Agresearch Limited Myostatine et mimetiques de ces derniers
TWI329129B (en) * 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
US7261893B2 (en) 2002-10-22 2007-08-28 Wyeth Neutralizing antibodies against GDF-8 and uses therefor
EP1635870A2 (fr) 2003-06-02 2006-03-22 Wyeth Utilisation des inhibiteurs du myostatin (gdf8) avec des corticosteroides pour le traitement des desordres neuromusculaires
US9045553B2 (en) 2004-05-27 2015-06-02 Acceleron Pharma, Inc. Cerberus/Coco derivatives and uses thereof
CA2567810A1 (fr) 2004-05-27 2005-12-08 Acceleron Pharma Inc. Derives de cerberus/coco et leurs applications
CN103450359B (zh) 2005-08-19 2018-07-24 惠氏有限责任公司 抗gdf-8的拮抗剂抗体以及在als和其他gdf-8-相关病症治疗中的用途
EP1951756B1 (fr) 2005-10-06 2015-01-07 Eli Lilly And Company Anticorps anti-myostatine
UA92504C2 (en) 2005-10-12 2010-11-10 Эли Лилли Энд Компани Anti-myostatin monoclonal antibody
PT2066695E (pt) 2006-09-05 2013-05-23 Lilly Co Eli Anticorpos anti-miostatina
EP2099471A2 (fr) 2006-12-08 2009-09-16 Acceleron Pharma, Inc. Utilisations de cerberus, de coco et de leurs dérivés
EP2861617A1 (fr) 2012-06-15 2015-04-22 Pfizer Inc. Anticorps antagonistes améliorés dirigés contre gdf-8 et leurs utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1333035A3 (fr) * 1993-03-19 2004-07-07 The Johns Hopkins University School Of Medicine Facteur GDF-8 de différentiation de croissance
ES2251721T3 (es) * 1994-07-08 2006-05-01 The Johns Hopkins University School Of Medicine Factor-11 de diferenciacion del crecimiento.
AU6274298A (en) * 1997-02-05 1998-08-25 Johns Hopkins University School Of Medicine, The Growth differentiation factor-8

Also Published As

Publication number Publication date
WO1999040181A1 (fr) 1999-08-12
CA2319703A1 (fr) 1999-08-12
AU2586199A (en) 1999-08-23

Similar Documents

Publication Publication Date Title
CA2319703C (fr) Facteur-8 de differenciation de la croissance
US6468535B1 (en) Growth differentiation factor-8
US6607884B1 (en) Methods of detecting growth differentiation factor-8
US7976839B2 (en) Growth differentiation factor-11
US20080213426A1 (en) Growth Differentiation Factor-8
US20020150577A1 (en) Use of antibodies specific for growth differentiation factor-11
US6465239B1 (en) Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species
WO1998033887A1 (fr) Facteur-8 de differenciation de croissance
US6517835B2 (en) Growth differentiation factor-11
CA2157577C (fr) Facteur-8 de differentiation de croissance
US6696260B1 (en) Methods to identify growth differentiation factor (GDF) binding proteins
US20080178310A1 (en) Growth Differentiation Factor-8 Nucleic Acid and Polypeptide from Aquatic Species, and Transgenic Aquatic Species
AU765832B2 (en) Growth differentiation factor-11
AU2003262440A1 (en) Growth differentiation factor-11
AU2006201079A1 (en) Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20190205